3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Grazax: new trials by email Literature Review of Grazax trials Research Report on Grazax
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction Dupixent®, Grazax®, Dupixent® Placebo - Allergic Rhinoconjunctivitis, Grass Pollen Allergy | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 199 | 2020-11-05 | 2026-04-27 |
| Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study Grazax, Grazax Placebo - Allergic Rhinitis | Phase 2 | Completed | Imperial College London | 46 | 2013-09-01 | 2019-12-04 |
| Long-Term Effects of Sublingual Grass Therapy Sublingual immunotherapy (SLIT), Subcutaneous immunotherapy (SCIT), Placebo - Rhinitis, Allergic, Seasonal | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 106 | 2011-03-01 | 2017-06-02 |
Rhinitis, Allergic, Seasonal (2) · Rhinitis, Allergic (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · Imperial College London (1)
United Kingdom (3)
Stephen Durham, MD (1) · Stephen R Durham, Prof. (1) · Stephen R. Durham, MD (1)
PMID 26682038, PMID 28196255, PMID 37460024
2018 (1)